QR Code

Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing

Saved in:
Main Authors: Charlotte L. B. M. Korst, Kaz Groen, Patricia W. C. Bosman, Fleur van derValk, Christie P. M. Verkleij, Sandy Kruyswijk, Maaike E. M. deRuijter, Dianne M. Heijink, Maria T. Kuipers, Sonja Zweegman, Niels W. C. J. van deDonk
Format: Artigo
Language:Inglês
Published: Wiley 2024-07-01
Series:HemaSphere
Online Access:https://doi.org/10.1002/hem3.132
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items